← Back to the plain-language case
Abstract pairs Ala510 with dA and Asn513 with dC; the paper's Results and Conclusion pair them the other way round
Nucleic Acids Res (2015) · doi:10.1093/nar/gkv760 · PMC4652769
Summary
The abstract states that "Ala510 and Asn513 facilitate incorporation of 8-oxo-dGMP opposite dA and dC, respectively". The body of the paper states the reverse pairing three times. The N513A paragraph of the Results concludes that "Asn513 plays an important role in facilitating 8-oxo-dGMP incorporation opposite dA". The Conclusion states that "Ala510 selectively enhances the incorporation of 8-oxo-dGMP opposite dC". The double-mutant paragraph describes "the opposite effects of Ala510 and Asn513, facilitating incorporation of the anti- and syn-conformations, respectively", and the paper ties the syn conformation to dA and the anti conformation to dC. The contradiction is between the abstract and the paper's own text, and that internal contradiction is the main basis of this report.
Table 1 supports the body text's assignment for Ala510 under both ways of summarising the data that I checked. For Asn513 the data support the body text (dA) on the absolute metric and are about even on the alternative metric; on neither metric do they support the abstract's dC assignment. The underlying kinetics and the Results text are internally consistent; the error is confined to one sentence of the abstract.
What the paper reports
Abstract (as archived in PMC):
Steady-state kinetics reveal that two residues lining the dNTP binding pocket, Ala510 and Asn513, play differential roles in dNTP selectivity. Specifically, Ala510 and Asn513 facilitate incorporation of 8-oxo-dGMP opposite dA and dC, respectively.
Results and Discussion, N513A paragraph:
However, the N513A substitution resulted in a much more drastic effect in the context of 8-oxo-dGMP incorporation opposite dA (25-fold, Figure 3D). Also, the catalytic efficiencies of dGMP and 8-oxo-dGMP incorporation opposite dC were reduced by 1.3 (Figure 3E) and 6.4-fold (Figure 3F) respectively. Taken together, these results suggest that Asn513 plays an important role in facilitating 8-oxo-dGMP incorporation opposite dA, implying that this residue selectively stabilizes the syn-conformation of 8-oxo-dGTP.
Results and Discussion, A510D paragraph:
Notably, the A510D substitution had the largest effect on the incorporation of 8-oxo-dGTP opposite dC (7.6-fold, Figure 3E) as opposed to dGTP (2.8-fold, Figure 3F). This suggests that Ala510 may preferentially stabilize the anti-conformation of 8-oxo-dGTP, promoting its incorporation opposite dC.
Results and Discussion, double-mutant paragraph:
Interestingly, the drop in catalytic efficiency was nearly identical for 8-oxo-dGMP incorporation opposite dA and dC. This is consistent with the opposite effects of Ala510 and Asn513, facilitating incorporation of the anti- and syn-conformations, respectively.
Conclusion:
As a consequence, Ala510 selectively enhances the incorporation of 8-oxo-dGMP opposite dC.
So the Results, the double-mutant interpretation and the Conclusion all assign Asn513 to the dA (syn) context and Ala510 to the dC (anti) context. The abstract's sentence assigns them the other way round.
What the paper's own numbers show
Method. Table 1 gives the catalytic efficiency kcat/KM (min⁻¹ µM⁻¹, mean ± SD of three independent experiments) for WT and each mutant, for the correct dNTP and for 8-oxo-dGTP, opposite both dA and dC. From those values I recomputed the fold loss of kcat/KM caused by each substitution (WT ÷ mutant) and compared it with the fold values printed in the Results text. I summarise each residue's template preference two ways, because the answer for Asn513 depends on which one is used:
- Metric 1, absolute fold loss. WT kcat/KM ÷ mutant kcat/KM for 8-oxo-dGTP, in each template context. This is the metric the abstract's wording ("facilitate incorporation ... opposite dA / dC") most directly implies, and the one on which the "reversed pairing" holds cleanly.
- Metric 2, loss relative to the correct dNTP. The 8-oxo-dGTP fold loss divided by the fold loss for the correct nucleotide (dTTP opposite dA, dGTP opposite dC) in the same context. This is the comparison the paper itself makes when it argues each residue's role, e.g. A510D 7.6-fold on 8-oxo-dGTP versus 2.8-fold on dGTP opposite dC.
Approximate SDs are first-order (delta-method) propagations of the Table 1 SDs on the log scale, treating WT and mutant as independent; with n = 3 per estimate they are a rough guide only. Every number below is printed by recompute.py.txt.
| Quantity | Location | Reported | Recomputed from Table 1 |
|---|---|---|---|
| A510D fold loss, 8-oxo-dGTP opposite dA | Results | 5.1-fold | 5.11× (SD ~0.65) |
| A510D fold loss, 8-oxo-dGTP opposite dC | Results | 7.6-fold | 7.57× (SD ~1.67) |
| N513A fold loss, 8-oxo-dGTP opposite dA | Results | 25-fold | 24.74× (SD ~3.19) |
| N513A fold loss, 8-oxo-dGTP opposite dC | Results | 6.4-fold | 6.39× (SD ~0.71) |
| A510D fold loss, dTTP opposite dA | Results | 4.8-fold | 4.78× |
| A510D fold loss, dGTP opposite dC | Results | 2.8-fold | 2.76× |
| N513A fold loss, dTTP opposite dA | Results | 5.8-fold | 5.82× |
| N513A fold loss, dGTP opposite dC | Results | 1.3-fold | 1.33× |
The Results-text values and the values recomputed from Table 1 agree throughout, so the contradiction is not between the Results and the table; it is between the abstract and the rest of the paper.
Which context does each residue affect more?
| Residue | Metric 1 (absolute): dA vs dC | larger at | Metric 2 (÷ correct dNTP): dA vs dC | larger at |
|---|---|---|---|---|
| Ala510 (A510D) | 5.11× vs 7.57× | dC (ratio 1.48; |log diff|/SD ~1.5) | 1.07 vs 2.74 | dC (ratio 2.57; |log diff|/SD ~2.6) |
| Asn513 (N513A) | 24.74× vs 6.39× | dA (ratio 3.87; |log diff|/SD ~7.9) | 4.25 vs 4.79 | about equal (ratio 1.13; |log diff|/SD ~0.4) |
Reading. On the absolute metric the pairing is the clean reverse of the abstract: Ala510's larger effect is opposite dC, Asn513's is opposite dA (and the Asn513 gap is large, ~8 approximate SDs). On the relative metric Ala510 is again larger opposite dC, by a clear margin, while Asn513 is essentially even between the two contexts (4.25 vs 4.79, well under one approximate SD apart). So:
- The abstract's Ala510 → dA assignment is contradicted on both metrics.
- The abstract's Asn513 → dC assignment is contradicted on the absolute metric and is, at best, not supported on the relative metric (the point estimate there is slightly larger opposite dC, but the difference is within noise). It is the body text's Asn513 → dA assignment, not the abstract's, that the absolute metric supports.
A consistency check favours the body text. For the double mutant the fold loss is nearly identical opposite dA (55.8×) and dC (58.9×), which the paper reads as Ala510 and Asn513 having opposite template preferences that cancel. That reading requires Asn513 → dA and Ala510 → dC, i.e. the body text, not the abstract. The Results also note that removing Asn513 cripples 8-oxo-dGTP opposite dA (25-fold) far more than it does the correct dTTP in the same context (5.8-fold), which is the paper's own argument that Asn513 selectively helps the dA (syn) mispair.
Figure
Figure 1. The abstract's sentence (left, orange) pairs Ala510 with the dA context and Asn513 with the dC context. The Results, Conclusion and double-mutant paragraphs (right) pair them the other way: Asn513 with dA (syn), Ala510 with dC (anti). The strip below lists, recomputed from Table 1, the fold loss of kcat/KM for 8-oxo-dGTP in each context, both as the absolute loss and divided by the loss for the correct dNTP (blue). Blue values are recomputed by recompute.py.txt; the abstract gives no numbers. The Results text prints the same absolute values, rounded.
Design candidates for review.
recompute.py.txtalso writes five candidate layouts incandidates/(cand1–cand5).fig1is currently a copy ofcand1(the two-panel text diagram) andfig2a copy ofcand3(a one-axis log plot of the fold losses). The final figure choice is open until the reader picks from the five candidates.
Why it matters
- The error is in the abstract, and inverts a headline mechanistic claim. The abstract's differential-role sentence is the paper's one-line summary of its kinetics. Readers, indexers and citing authors who see only the abstract take away the reverse of what the Results, Conclusion and Table 1 support: that Ala510 helps 8-oxo-dGMP opposite dA and Asn513 opposite dC.
- The directions connect to different conformations. The paper links the dA mispair to the syn conformation (stabilised by the Asn513 hydrogen bond to the C8-carbonyl) and the dC pairing to the anti conformation (where the A510D paragraph invokes an unfavourable electrostatic contact). Swapping the residues swaps which conformation each is said to stabilise, which is a mechanistic claim, not just a labelling slip.
- The data and the analysis are not affected. Table 1, the Results text and the Conclusion are internally consistent. Only the abstract sentence is wrong, so the correction is a one-sentence fix.
Explanations considered
- A reader could pick the abstract's pairing out of the numbers on some metric. Not supported. On the absolute fold loss the pairing is the clean reverse of the abstract. On the loss relative to the correct dNTP, Ala510 is still clearly larger opposite dC, and Asn513 is about even (4.25 vs 4.79) rather than larger opposite dC. Neither metric gives Ala510 → dA, and neither gives a clear Asn513 → dC. The abstract's own body text states the reverse pairing explicitly in three places.
- "Respectively" was meant to map to "dC and dA". Not supported. English "A and B ... opposite dA and dC, respectively" maps A→dA, B→dC, and the sentence names Ala510 before Asn513. Reading it the other way would make it agree with the body, but that is not what the sentence says.
- A different measure of "facilitate". The abstract gives no numbers, so "facilitate ... opposite dA / dC" can only be read as the fold effect of each substitution in each context. Both the metrics I checked place Ala510's larger effect opposite dC; neither supports Ala510 → dA.
- A correction already issued. None found (see Status).
Status
- Checks performed.
- (1) Recompute: the 10 fold values printed in the Results text all match the values recomputed from Table 1 (see the table above);
recompute.py.txtprints them. - (2) Numbers in this write-up: every figure and number drawn here comes from Table 1 or from
recompute.py.txt; none is a new claim. - (4) Tone: the write-up reports the internal contradiction and the metric dependence without speculating about cause or naming any person.
- (5) This Status section records each check and its date.
- (6) Markdown and image links: the figure link points to
fig1.svg, which exists in this folder; the candidate layouts are incandidates/. - Version of record. On 2026-10-23 the abstract sentence and the 16 kcat/KM values of Table 1 were compared with the publisher's HTML page (academic.oup.com, via the DOI) and with the Europe PMC core record (PMID 26220180); the abstract sentence and all 16 values match. Every quotation above was also checked verbatim against the PMC-archived text with
src/show.py. - Corrections and comments. As of 2026-10-23 I found no correction, erratum, retraction or expression of concern.
src/known.pyreturns no Crossref update relations, no PMC notices and no Europe PMC notices. A web search for the title together with "PubPeer", "correction" and "erratum" returned only the paper and its PDB entries. - Figure-panel citations. This write-up cites Table 1 for all numbers and does not rely on figure-panel letters. The paper's Results label some Figure 3 panels inconsistently between the A510D and N513A paragraphs (e.g. 8-oxo-dGMP opposite dC is cited as Figure 3E in one paragraph and the dGMP/8-oxo-dGMP panels are cited as 3E/3F in another); because this write-up cites Table 1 only, that inconsistency does not affect it.
- Sources. PMC article PMC4652769; publisher page academic.oup.com (doi:10.1093/nar/gkv760); Europe PMC core record (PMID 26220180); Crossref; PMC and Europe PMC notice feeds; https://doi.org/10.1093/nar/gkv760.
Suggested correction
In the abstract, replace
Specifically, Ala510 and Asn513 facilitate incorporation of 8-oxo-dGMP opposite dA and dC, respectively.
with
Specifically, Ala510 and Asn513 facilitate incorporation of 8-oxo-dGMP opposite dC and dA, respectively.
(or, equivalently, "Asn513 and Ala510 ... opposite dA and dC, respectively"), so that the abstract agrees with the Results, the Conclusion, the double-mutant interpretation and Table 1.